Avista Capital-backed eMolecules completed the acquisition of Frontier Scientific and Frontier Agricultural Sciences.

Avista Capital Partners-backed eMolecules, a chemistry search-and-fulfillment platform for early drug discovery research, completed the acquisition of specialty chemical manufacturers Frontier Scientific and Frontier Agricultural Sciences. Financial terms were not disclosed. "We are truly excited to welcome the FSI and FAS teams into the eMolecules family. Our shared dedication to providing outstanding customer service and delivering specialized solutions that simplify the lives of chemistry researchers were the primary drivers behind this combination. We have worked with Frontier for many years and have been impressed and enthused by the talent that will now be joining and complementing our growing team," Niko Gubernator, eMolecules CEO and President.